Evidence map›Paper›PMID 32163370›Full record

ArticleeLife2020

ATR expands embryonic stem cell fate potential in response to replication stress.

Sina Atashpaz, Sara Samadi Shams, Javier Martin Gonzalez, Endre Sebestyén, Negar Arghavanifard, Andrea Gnocchi, Eliene Albers, Simone Minardi, Giovanni Faga, Paolo Soffientini and 8 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 6 countries.

Sina Atashpaz *IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0003-0566-5629
Sara Samadi Shams *IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0002-1697-9343
Javier Martin GonzalezTransgenic Core Facility, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-7075-6028
Endre SebestyénIFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0001-5470-2161
Negar ArghavanifardIFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0003-3039-7603
Andrea GnocchiIFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0003-3290-9449
Eliene AlbersCenter for Chromosome Stability and Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
Simone MinardiIFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0001-7303-3821
Giovanni FagaExperimental Therapeutics Program, IFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
Paolo SoffientiniIFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
Elisa AllieviCogentech, IFOM-The FIRC Institute of Molecular Oncology Milan, Milan, Italy.
Valeria CancilaTumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine Palermo, Palermo, Italy.
Angela BachiIFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
Óscar Fernández-CapetilloSpanish National Cancer Research Center, Madrid, Spain.
Claudio TripodoTumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine Palermo, Palermo, Italy.
Francesco FerrariIFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.
Andrés Joaquin López-ContrerasCenter for Chromosome Stability and Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
Vincenzo CostanzoIFOM-The FIRC Institute of Molecular Oncology, Milan, Italy.ORCID 0000-0002-2920-9508
IFOM · ITUniversity of Copenhagen · DKUniversity of Milan · ITGovernment of Western Australia Department of Health · AUScience for Life Laboratory · SE

Funding

Associazione Italiana per la Ricerca sul Cancro 23961Danish Cancer Society KBVU-2014Danish National Research Foundation DNRF115European Research Council 614541European Research Council ERC-2015-STG-679068Fondazione Italiana per la Ricerca sul Cancro FIRC 18112
6 · The paper itself

Abstract

Unrepaired DNA damage during embryonic development can be potentially inherited by a large population of cells. However, the quality control mechanisms that minimize the contribution of damaged cells to developing embryos remain poorly understood. Here, we uncovered an ATR- and CHK1-mediated transcriptional response to replication stress (RS) in mouse embryonic stem cells (ESCs) that induces genes expressed in totipotent two-cell (2C) stage embryos and 2C-like cells. This response is mediated by

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsCell DifferentiationCell ProliferationCells, CulturedCheckpoint Kinase 1ChimeraChromatography, LiquidCloning, MolecularDNA DamageEmbryonic Stem CellsGene Expression RegulationMiceRNA, MessengerSequence Analysis, RNATandem Mass SpectrometryAtaxia Telangiectasia Mutated ProteinsAtr protein, mouseCheckpoint Kinase 1Chek1 protein, mouseRNA, MessengerATRcell biologyembryonic stem cellmousereplication stress

Identifiers

PMID32163370
PMCPMC7067586
OpenAlexW3010831807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.